Magnesium
Half-Life (t½) PO: 12h · IV: 12h
Daily Value (RDI) 420 mg (UL: 350 mg)
Formula Mg
Molecular Weight 24.31 g/mol
Aliases Mg²⁺, Mg glycinate, Mg citrate, Mg malate, Mg threonate Pharmacological Mechanism Mg²⁺ stabilises ATP (Mg-ATP is the catalytically active form) and serves as a cofactor for 300+ enzymes including kinases, phosphatases, and glycolytic/TCA/oxidative phosphorylation steps. Voltage-dependent block of glutamate receptor pharmacology receptor Ca²⁺ channels drives the sleep-onset and neuroprotective effects. Required for DNA/RNA and protein synthesis. CNS penetration is form-dependent — threonate raises CSF Mg²⁺ measurably in rodent models (Slutsky 2010).
Dietary Reference Intake FDA Daily Value 420 mg (21 CFR 101.9). NIH ODS UL 350 mg/d applies only to SUPPLEMENTAL magnesium; dietary intake above is generally safe.
Half-Life & Elimination Curve (PO: 12h · IV: 12h) 100% 50% 25% 12.5% 0% 0h 0×t½ 12h 1×t½ 24h 2×t½ 36h 3×t½ 48h 4×t½ 60h 5×t½ 0×t½ (0h): 100% remaining (~0.105 mg/L) 1×t½ (12h): 50% remaining (~52.7 µg/L) 2×t½ (24h): 25% remaining (~26.4 µg/L) 3×t½ (36h): 12.5% remaining (~13.2 µg/L) 4×t½ (48h): 6.3% remaining (~6.59 µg/L) 5×t½ (60h): 3.1% remaining (~3.3 µg/L) Plasma (PO) t½ Decay (12h)
0×t½ 0h 100% (0.105 mg/L) 1×t½ 12h 50% (52.7 µg/L) 2×t½ 24h 25% (26.4 µg/L) 3×t½ 36h 12.5% (13.2 µg/L) 4×t½ 48h 6.3% (6.59 µg/L) 5×t½ 60h 3.1% (3.3 µg/L) Dosing Guidelines Oral (PO): Typical 367 mg (Range: 300–500 mg)Transdermal (TD): Typical 367 mg (Range: 300–500 mg)Intravenous (IV): Typical 367 mg (Range: 300–500 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 40% · Volume of Distribution (Vd): 1050 L · Absorption (ka): 0.5 h⁻¹ (t½ka ≈ 1.39h) [PMID 11550076 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 1050 L [PMID 11550076 ]Pathways It Modulates Target Organ Systems Interactions Vitamin D3 (synergistic): Bidirectional cofactor: D3 needs Mg for activation; Mg supports VDR-mediated gene expression.Calcium (caution): Shared intestinal transporters; high-dose Ca can reduce Mg absorption. Separate by 2 h or keep combined dose moderate.Zinc (caution): Competes for DMT1 transporter at high doses. Take 2 h apart.Aspartate (synergistic): Magnesium aspartate chelate — mutual tissue-uptake enhancement.Magnesium BHB (synergistic): Same cation pool — count combined intake to avoid GI overload.Magnesium Citrate (synergistic): Same elemental mineral — citrate is the common OTC baseline.Magnesium Glycinate (synergistic): Same elemental mineral — glycinate is a preferred low-GI form.Magnesium Malate (synergistic): Same elemental mineral; malate is the fibromyalgia-focused form.Magnesium Taurate (synergistic): Same elemental mineral; taurate is the CV-focused form.Magnesium L-Threonate (synergistic): Same elemental mineral; threonate is specifically the CNS-targeted form.Calcifediol (synergistic): Required cofactor for downstream 1α-hydroxylation and VDR activation.Calcitriol (synergistic): Cofactor for VDR activation; ensure Mg sufficiency before dose escalation.Vitamin D2 (synergistic): Required cofactor for 25- and 1α-hydroxylation of both D2 and D3.Pyridoxine (synergistic): P5P improves intracellular Mg²⁺ uptake; classic 'P5P + Mg glycinate' stack for premenstrual/anxious symptoms.Top Dietary Sources Chemical Structure & Identifiers InChIKey: FYYHWMGAXLPEAU-UHFFFAOYSA-NSMILES: [Mg]References Directory Compounds Registry Human Biology Hub